PBMCs were matured into dendritic cells using a published protocol [46]. PBMCs are cultured in dendritic base media. Briefly, AIM V cell culture media (Invitrogen) is supplemented with 10% human serum albumin (Gemini BioScience), β-mercaptoethanol (50μM), 1% Penicillin/Streptomycin, 0.1% amphotericin B, 800 U/mL GM-CSF (LifeTechmologies), 500 U/mL IL-4 (LifeTechnologies). After three days cells were fed with dendritic base media. On day 5 immature dendritic cells were fed with dendritic base media supplemented with 5 ng/mL TNF (Life Technologies), 5 ng/mL IL-1β (Life Technologies), 150 ng/mL IL-6 (Life Technologies), and 1 μg/mL prostaglandin E2 (PGE2; Life Technologies). On day 6 mature dendritic cells were shorted by fluorescence-activated cell sorting (FACs) for the expression of HLA-DR (Biolegend). On day 7 FACs sorted mature dendritic cells were co-cultured with control or H. pylori huFGOs.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.